(Q38118386)

29 August 2017

Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms race (English)

1 reference

29 August 2017

multiple drug resistance

1 reference

based on heuristic

inferred from title

author

Frederik Van den Broeck

object named as

Frederik Van den Broeck

3

0 references

Manu Vanaerschot

object named as

Manu Vanaerschot

1

0 references

Silvie Huijben

2

0 references

author name string

Jean-Claude Dujardin

4

1 reference

29 August 2017

22 July 2013

1 reference

FEMS Microbiology Reviews

29 August 2017

1 reference

29 August 2017

38

1 reference

29 August 2017

1

1 reference

29 August 2017

41-55

1 reference

Evolution of drug-resistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in Eastern Sudan

29 August 2017

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Genetic diversity and population structure of Schistosoma mansoni within human infrapopulations in Mwea, central Kenya assessed by microsatellite markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Persistence of antibiotic resistance in bacterial populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

A new model of progressive visceral leishmaniasis in hamsters by natural transmission via bites of vector sand flies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Characterization of Within-Host Plasmodium falciparum Diversity Using Next-Generation Sequence Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Drug resistant Plasmodium falciparum in an area of seasonal transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Light and electron microscopic studies on the effect of praziquantel on Schistosoma mansoni, Dicrocoelium dendriticum, and Fasciola hepatica (Trematoda) in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Natural infection of Phlebotomus argentipes with Leishmania and other trypanosomatids in a visceral leishmaniasis endemic region of Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Schistosoma mansoni: hycanthone/oxamniquine resistance is controlled by a single autosomal recessive gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Drug resistance in schistosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Antischistosomal drugs: past, present ... and future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Determination of ED50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Leishmania resistance to miltefosine associated with genetic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Sustainable use of anthelmintics in grazing animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Resistance of Schistosoma mansoni to praziquantel: is there a problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Artemisinin Resistance in Plasmodium falciparum Malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Artemisinin resistance: current status and scenarios for containment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Evidence that mutant PfCRT facilitates the transmission to mosquitoes of chloroquine-treated Plasmodium gametocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

The influence of drug treatment on the maintenance of schistosome genetic diversity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

New delivery strategies for the old pentavalent antimonial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Leishmania donovani develops resistance to drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Drug resistance in human helminths: current situation and lessons from livestock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Population genetic structure of Schistosoma mansoni and Schistosoma haematobium from across six sub-Saharan African countries: implications for epidemiology, evolution and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Spatial risk prediction and mapping of Schistosoma mansoni infections among schoolchildren living in western Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

21 January 2018

Human schistosomiasis

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Use of antimony in the treatment of leishmaniasis: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

The origins of antimalarial drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

21 January 2018

Drug-resistant malaria

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Drug resistance mechanisms in helminths: is it survival of the fittest?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Artemisinins and synthetic trioxolanes in the treatment of helminth infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Clinically immune hosts as a refuge for drug-sensitive malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Variation of Plasmodium falciparum msp1 block 2 and msp2 allele prevalence and of infection complexity in two neighbouring Senegalese villages with different transmission conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Return of chloroquine antimalarial efficacy in Malawi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Plasmodium falciparum: infectivity of cultured, synchronized gametocytes to mosquitoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Biological characteristics of praziquantel-resistant and -susceptible isolates of Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Diversity of Plasmodium falciparum clones infecting children living in a holoendemic area in north-eastern Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Adaptive mechanisms in pathogens: universal aneuploidy in Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Severe Candida spp. infections: new insights into natural immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Antimalarial drugs: modes of action and mechanisms of parasite resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Close kinship within multiple-genotype malaria parasite infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Schistosoma mansoni in infants (aged < 3 years) along the Ugandan shoreline of Lake Victoria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

A benzodiazepine derivative and praziquantel: effects on musculature of Schistosoma mansoni and Schistosoma japonicum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Alterations in cytochrome-c oxidase expression between praziquantel-resistant and susceptible strains of Schistosoma mansoni.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Mutations in cytochrome b resulting in atovaquone resistance are associated with loss of fitness in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Hycanthone resistance in schistosomes correlates with the lack of an enzymatic activity which produces the covalent binding of hycanthone to parasite macromolecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone/oxamniquine-resistant strains are mutated in the same gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Genetic variability following selection of Haemonchus contortus with anthelmintics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Evolutionary biology and the avoidance of antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

The ecology of genetically diverse infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

"Everything you always wanted to know about sex (but were afraid to ask)" in Leishmania after two decades of laboratory and field analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Population genetics of Schistosoma japonicum within the Philippines suggest high levels of transmission between humans and dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Antimony resistance and environment: Elusive links to explore during Leishmania life cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Effect of pyrimethamine resistance on sporogony in a Plasmodium berghei/Anopheles stephensi model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Monitoring antimalarial resistance: launching a cooperative effort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Progression of Plasmodium berghei through Anopheles stephensi is density-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Mosquito transmission of the rodent malaria parasite Plasmodium chabaudi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Genetic diversity and population structuring of Schistosoma mansoni in a Brazilian village

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Efficient genotyping of Schistosoma mansoni miracidia following whole genome amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Genetic analysis of the human malaria parasite plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Fitness of drug-resistant malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Susceptibility or resistance of praziquantel in human schistosomiasis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Rational use of drugs against Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Evolutionary concepts in predicting and evaluating the impact of mass chemotherapy schistosomiasis control programmes on parasites and their hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

The assessment of antimalarial drug efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

On the role of schistosome mating structure in the maintenance of drug resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1574-6976.12032

21 January 2018

Identifiers

DOI

10.1111/1574-6976.12032

1 reference

29 August 2017

1 reference

PubMed ID

23815683